Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Alba Therapeutics Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Alba Therapeutics Corporation - Product Pipeline Review - 2014', provides an overview of the Alba Therapeutics Corporation's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Alba Therapeutics Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Alba Therapeutics Corporation including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Alba Therapeutics Corporation's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Alba Therapeutics Corporation's pipeline products Reasons to buy - Evaluate Alba Therapeutics Corporation's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Alba Therapeutics Corporation in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Alba Therapeutics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Alba Therapeutics Corporation and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Alba Therapeutics Corporation - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Alba Therapeutics Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Alba Therapeutics Corporation Snapshot 5 Alba Therapeutics Corporation Overview 5 Key Information 5 Key Facts 5 Alba Therapeutics Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 Alba Therapeutics Corporation - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Alba Therapeutics Corporation - Pipeline Products Glance 11 Alba Therapeutics Corporation - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Alba Therapeutics Corporation - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Alba Therapeutics Corporation - Drug Profiles 15 larazotide acetate 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 AT-1004 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 AT-1006 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 AT-1005 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Drug 1 to Inhibit Permeability for Autoimmune Disorders and Inflammation 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Drug 2 to Inhibit Permeability for Autoimmune Disorders and Inflammation 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Alba Therapeutics Corporation - Pipeline Analysis 22 Alba Therapeutics Corporation - Pipeline Products by Target 22 Alba Therapeutics Corporation - Pipeline Products by Route of Administration 23 Alba Therapeutics Corporation - Pipeline Products by Molecule Type 24 Alba Therapeutics Corporation - Pipeline Products by Mechanism of Action 25 Alba Therapeutics Corporation - Recent Pipeline Updates 26 Alba Therapeutics Corporation - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables Alba Therapeutics Corporation, Key Information 5 Alba Therapeutics Corporation, Key Facts 5 Alba Therapeutics Corporation - Pipeline by Indication, 2014 8 Alba Therapeutics Corporation - Pipeline by Stage of Development, 2014 9 Alba Therapeutics Corporation - Monotherapy Products in Pipeline, 2014 10 Alba Therapeutics Corporation - Phase II, 2014 11 Alba Therapeutics Corporation - Phase I, 2014 12 Alba Therapeutics Corporation - Preclinical, 2014 13 Alba Therapeutics Corporation - Discovery, 2014 14 Alba Therapeutics Corporation - Pipeline by Target, 2014 22 Alba Therapeutics Corporation - Pipeline by Route of Administration, 2014 23 Alba Therapeutics Corporation - Pipeline by Molecule Type, 2014 24 Alba Therapeutics Corporation - Pipeline Products by Mechanism of Action, 2014 25 Alba Therapeutics Corporation - Recent Pipeline Updates, 2014 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.